Prevelance of haemoglobinophaties in Gujarat, India: A cross-sectional study

Internet Journal of Hematology

Volumn 5, Issue 1, 2009, Pages

  Patel, Jagruti ^a   Patel, Ashwin ^b   Patel, Jigar ^c   Kaur, Amarjeet ^d   Patel, Vinod ^d  

^a NIRMA UNIVERSITY   (India)

^b Narayan Complex   (India)

^c Arihant School of Pharmacy   (India)

^d Green Cross Pathology   (India)

Author keywords

Electrophoresis; Haemoglobin S; Haemoglobinopathy; HPLC; Thalassaemia

Indexed keywords

HEMOGLOBIN A; HEMOGLOBIN F; HEMOGLOBIN S;

ADULT; ANEMIA; ARTICLE; BETA THALASSEMIA; BLOOD SAMPLING; BLOOD TRANSFUSION; FEMALE; HEMOGLOBIN D DISEASE; HEMOGLOBIN E DISEASE; HEMOGLOBIN E THALASSEMIA; HEMOGLOBIN E TRAIT; HEMOGLOBINOPATHY; HETEROZYGOTE; HUMAN; INDIA; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; PREVALENCE; RETROSPECTIVE STUDY; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; SICKLE CELL TRAIT; THALASSEMIA MAJOR; THALASSEMIA MINOR;

EID: 77953373326     PISSN: None     EISSN: 15402649     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Stuart MJ, Nagel RL. Sickel Cell Disease. Lancet 2004; 364:1343-1360
2. Mohanty D, Mukherjee MB. Sickle Cell Disease in India. Curr Opin Hematol 2002;9:117-122.
3. Sarnaik S. Thalassemia and related hemoglobinopathies. Indian J Pediatr 2005; 72:319-324.
4. Majumder PP, Roy B, Balgir RS, Dash BP. Polymorphisms in the beta-globin gene cluster in some ethnic populations of India and their implications on disease. In: Gupta S, and Sood OP, editors. Molecular Intervention in Disease. New Delhi: Ranbaxy Science Foundation; 1998. p.75-83.
5. Balgir RS. The genetic burden of hemoglobinopathies with special reference to community health in India and the challenges ahead. Indian J Hemat Blood Transfus 2002; 20:2-7.
6. Balgir RS. Genetic epidemiology of the three predominant abnormal hemoglobins in India. J Assoc Physicians India 1996; 44:25-28.
7. WHO-EXECUTIVE BOARD EB118/5, 118th Session Report by the Secretariat on Thalassaemia and other haemoglobinopathies: Prevalence of Haemoglobinopathies. 11 May 2006; p. 1-8.
8. Varawalla NY, Old JM, Sarkar R, Venkatean R, Weatherall DJ. The spectrum of beta thalassaemia mutations on the Indian subcontinent; the basis of prenatal diagnosis. Br J Haematol 1991;78:242-247.
9. Das BM, Deka R, Das R. Haemoglobin E in six populations of Assam. Ind J Anthrop Assoc 1980;15:153-156.
10. Balgir RS, Sharma SK. Distribution of sickle cell hemoglobin in India. Indian J Hemat 1988; 6: 1-14.
11. Menon A, Salim KA. Sickle cell disease in South India. J Assoc Physicians India 1993; 41: 617.
12. Balgir RS. Aberrant heterosis in hemoglobinopathies with special reference to - thalassemia and structurally abnormal hemoglobins E and S in Orissa, India. J Clin Diagn Res 2007; 1: 122-130.
13. Deka R. Fertility and haemoglobin genotypes: A population study in upper Assam (India). Hum Genet 1981; 59: 172-174
14. Balgir RS. The spectrum of hemoglobin variants in two scheduled tribes of Sundargarh district in Northwestern Orissa, India. Ann Hum Biol 2005; 32: 560-573.
15. Desai SS, Master H, Chavan DS, Sukumaran PK. Homozygous Sickle cell disease. Indian J Hematol 1986; 4: 71-74.
16. Agarwal S, Gupta UR, Kohli N, Verma C, Agarwal SS. Prevalence of haemoglobin D in Uttar Pradesh. Ind J Med Res 1989; 90:39-43.
17. Sukumaran PK. Abnormal haemoglobin in India. In: Sen NN, editor. Trends in hematology. JB Chatterjee Memorial Volume. Calcutta; 1975. p. 225-261.
18. Ambekar SS, Phadke MA, Mokashi GD, Bankar MP, Khedkar VA, Venkat V, et al. Pattern of haemoglobinopathies in western Maharastra. Indian Pediatr 2001; 38: 530-534.
19. Kar BC, Satapathy RK, Kulozik AE, Kulozik M, Sirr S, Serjeant BE. Sickle cell disease in Orissa state, India. Lancet. 1986; 2: 1198-1201.
20. Balgir RS. Reproductive profile of mothers in relation to hemoglobin E genotypes. Indian J Pediatr 1992; 59: 449-454.
21. Balgir RS. The burden of haemoglobinopathies in India and the challenges ahead. Curr Sci: 2000; 79: 1536-1547.
22. Shah A. Thallassemia syndromes. Indian J Med Sci 2004; 58: 445-449.
23. Beutler E. The Sickle cell diseases and related disorders. In: Beutler E, Lichtman MA, Coller BS, Kipps JT, Seligsohn U, editors. Williams Hematology. New York: McGraw-Hill; 6th International ed. 2001. p. 581-606.
24. Wild BJ, Bain BJ. Investigation of abnormal haemoglobins and thalassaemia. In: Dacie JV, Lewis SM, editors. Dacie and Lewis Practical haematology, 9th ed. Edinburgh. Churchill Livingstone, 2001. p. 231-268.
25. Labie D, Srinivas R, Dunda O, Dode C, Lapoumeroulie C, Devi V, et al. Haplotypes in tribal Indians bearing the sickle gene: evidence for the unicentric origin of the beta S mutation and the unicentric origin of the tribal populations of India. Hum Biol 1989; 161: 479-491.
26. Angastiniotis M, Kyriakidou S, Hadjiminas M. How thalassaemia was controlled in Cyprus. World Health Forum 1986; 7:291-297.
27. Kattamis C, Metaxatou-Mavromati A, Wood WG. The heterogeneity of normal HbA2 beta thalassaemia in Greece. Br J Haematol 1979; 42: 109-123.
28. Streetly A, Dick M. Screening for haemoglobinopathies. Curr Paediatr 2005; 15: 32-39.
29. Agarwal MB. The Burden of Haemoglobinopathics in India - Time to Wake Up? J Assoc Physicians India 2005; 53: 1017-1018.
30. Haemoglobinopathies: Patient and family fact sheet. In. Genetics in Family Medicine: The Australian Handbook for General Practitioners. 2007. p. 1- 17.